Journal article
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning – Results from the EU-GEI study
S Menghini-Müller, E Studerus, S Ittig, U Heitz, L Egloff, C Andreou, LR Valmaggia, MJ Kempton, M van der Gaag, L de Haan, B Nelson, N Barrantes-Vidal, M Nordentoft, S Ruhrmann, G Sachs, BP Rutten, JV Os, A Riecher-Rössler
European Psychiatry | CAMBRIDGE UNIV PRESS | Published : 2019
Abstract
Background: Gender differences in symptomatology in chronic schizophrenia and first episode psychosis patients have often been reported. However, little is known about gender differences in those at risk of psychotic disorders. This study investigated gender differences in symptomatology, drug use, comorbidity (i.e. substance use, affective and anxiety disorders)and global functioning in patients with an at-risk mental state (ARMS)for psychosis. Methods: The sample consisted of 336 ARMS patients (159 women)from the prodromal work package of the EUropean network of national schizophrenia networks studying Gene-Environment Interactions (EU-GEI; 11 centers). Clinical symptoms, drug use, comorbi..
View full abstractGrants
Awarded by Medical Research Council
Funding Acknowledgements
This work was supported by the European Union (European Community's Seventh Framework Program [grant number HEALTH-F2-2010-241909; Project EU-GEI]). M.J.K. was supported by a Medical Research Council Fellowship [grant number MR/J008915/1].